NCT01331317View on ClinicalTrials.gov

Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type 1 DM and Diabetic Nephropathy

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Cardiovascular DiseaseDiabetic Nephropathy
Interventions
DRUG

Paricalcitol

capsule, 1-2 micrograms daily for 90 days

Trial Locations (1)

2400

Steno Diabetes Center A/S, Gentofte Municipality

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Peter Rossing

OTHER

NCT01331317 - Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type 1 DM and Diabetic Nephropathy | Biotech Hunter | Biotech Hunter